Patents by Inventor Pedro Bobe

Pedro Bobe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of autoimmune and inflammatory diseases with the arsenic compounds AS2O3 and/or AS2O5 administered locally
    Patent number: 10438128
    Abstract: The invention concerns the field of human auto-immune and/or inflammatory diseases, and more specifically the use of arsenic compounds for the preparation of drugs intended for the treatment and/or prevention of skin injuries associated with auto-immune and/or inflammatory diseases in a human subject. The invention concerns an arsenic compound As2O5 for use in the treatment and/or prevention of skin injuries associated with auto-immune and/or inflammatory diseases in a human subject, a pharmaceutical composition comprising an arsenic compound As2O5, preferably for the treatment and/or prevention of skin injuries associated with auto-immune diseases in a human subject, and products containing an arsenic compound As2O5 and an arsenic compound As2O3 as a combination product for simultaneous, separated or time-spread use in the treatment and/or prevention of skin injuries associated with auto-immune diseases in a human subject.
    Type: Grant
    Filed: April 25, 2014
    Date of Patent: October 8, 2019
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), UNIVERSITE PARIS-SUD 11
    Inventors: Mohcine Benbijja, Pedro Bobe
  • TREATMENT OF SKIN INJURIES ASSOCIATED WITH AUTO-IMMUNE AND INFLAMMATORY DISEASES USING THE ARSENIC COMPOUND AS205
    Publication number: 20180189671
    Abstract: The invention concerns the field of human auto-immune and/or inflammatory diseases, and more specifically the use of arsenic compounds for the preparation of drugs intended for the treatment and/or prevention of skin injuries associated with auto-immune and/or inflammatory diseases in a human subject. The invention concerns an arsenic compound As2O5 for use in the treatment and/or prevention of skin injuries associated with auto-immune and/or inflammatory diseases in a human subject, a pharmaceutical composition comprising an arsenic compound As2O5, preferably for the treatment and/or prevention of skin injuries associated with auto-immune diseases in a human subject, and products containing an arsenic compound As2O5 and an arsenic compound As2O3 as a combination product for simultaneous, separated or time-spread use in the treatment and/or prevention of skin injuries associated with auto-immune diseases in a human subject.
    Type: Application
    Filed: April 25, 2014
    Publication date: July 5, 2018
    Inventors: Mohcine BENBIJJA, Pedro BOBE
  • Arsenic therapy for APLS-type autoimmune lymph-oproliferative syndrome in mice and humans
    Patent number: 8497300
    Abstract: The invention relates to the use of an arsenic compound for the preparation of a medicament that is used to treat autoimmune diseases.
    Type: Grant
    Filed: October 2, 2008
    Date of Patent: July 30, 2013
    Assignee: Centre National de la Recherche Scientifique (CNRS)
    Inventors: Kmar Chelbi Alix, Pedro Bobe
  • Arsenic therapy for autoimmune and/or inflammatory diseases in mice and humans
    Patent number: 8394422
    Abstract: The invention relates to a method for treating and/or preventing autoimmune and/or inflammatory diseases, including the graft-versus-host disease, comprising administering to a patient in need thereof, a therapeutically effective amount of an arsenic compound or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: June 8, 2009
    Date of Patent: March 12, 2013
    Assignee: Centre National de la Recherche Scientifique (CNRS)
    Inventors: Kmar Chelbi Alix, Pedro Bobé
  • ARSENIC THERAPY FOR AUTOIMMUNE AND/OR INFLAMMATORY DISEASES IN MICE AND HUMANS
    Publication number: 20090297624
    Abstract: The invention relates to a method for treating and/or preventing autoimmune and/or inflammatory diseases, including the graft-versus-host disease, comprising administering to a patient in need thereof, a therapeutically effective amount of an arsenic compound or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 8, 2009
    Publication date: December 3, 2009
    Inventors: Kmar Chelbi Alix, Pedro Bobe
  • ARSENIC THERAPY FOR APLS-TYPE AUTOIMMUNE LYMPH-OPROLIFERATIVE SYNDROME IN MICE AND HUMANS
    Publication number: 20090098216
    Abstract: The invention relates to the use of an arsenic compound for the preparation of a medicament that is used to treat autoimmune diseases.
    Type: Application
    Filed: October 2, 2008
    Publication date: April 16, 2009
    Inventors: Kmar Chelbi Alix, Pedro Bobe
  • Arsenic therapy for apls-type autoimmune lymph-oproliferative syndrome in mice and humans
    Publication number: 20050163863
    Abstract: The invention relates to the use of an arsenic compound for the preparation of a medicament that is used to treat autoimmune diseases.
    Type: Application
    Filed: April 25, 2003
    Publication date: July 28, 2005
    Inventors: Kmar Chelbi Alix, Pedro Bobe